165 related articles for article (PubMed ID: 22274410)
21. The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer.
Lubeck DP; Grossfeld GD; Carroll PR
Urology; 2001 Aug; 58(2 Suppl 1):94-100. PubMed ID: 11502459
[TBL] [Abstract][Full Text] [Related]
22. Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.
Gandaglia G; Fossati N; Karnes RJ; Boorjian SA; Colicchia M; Bossi A; Seisen T; Cozzarini C; Di Muzio N; Noris Chiorda B; Zaffuto E; Wiegel T; Shariat SF; Goldner G; Joniau S; Battaglia A; Haustermans K; De Meerleer G; Fonteyne V; Ost P; Van Poppel H; Montorsi F; Briganti A
Eur Urol; 2018 Apr; 73(4):512-518. PubMed ID: 29229176
[TBL] [Abstract][Full Text] [Related]
23. Influence of urological morbidity on quality of life in patients with prostate cancer.
Fosså SD; Woehre H; Kurth KH; Hetherington J; Bakke H; Rustad DA; Skånvik R
Eur Urol; 1997; 31 Suppl 3():3-8. PubMed ID: 9101208
[TBL] [Abstract][Full Text] [Related]
24. Antiandrogen therapy and side effects following radical prostatectomy.
Clin J Oncol Nurs; 2000; 4(4):179-80. PubMed ID: 11261099
[No Abstract] [Full Text] [Related]
25. Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.
Lardas M; Liew M; van den Bergh RC; De Santis M; Bellmunt J; Van den Broeck T; Cornford P; Cumberbatch MG; Fossati N; Gross T; Henry AM; Bolla M; Briers E; Joniau S; Lam TB; Mason MD; Mottet N; van der Poel HG; Rouvière O; Schoots IG; Wiegel T; Willemse PM; Yuan CY; Bourke L
Eur Urol; 2017 Dec; 72(6):869-885. PubMed ID: 28757301
[TBL] [Abstract][Full Text] [Related]
26. Androgen deprivation therapy before radical prostatectomy is associated with poorer postoperative erectile function outcomes.
Mazzola CR; Deveci S; Heck M; Mulhall JP
BJU Int; 2012 Jul; 110(1):112-6. PubMed ID: 22093870
[TBL] [Abstract][Full Text] [Related]
27. Evaluating the Trade-Offs Men with Localized Prostate Cancer Make between the Risks and Benefits of Treatments: The COMPARE Study.
Watson V; McCartan N; Krucien N; Abu V; Ikenwilo D; Emberton M; Ahmed HU
J Urol; 2020 Aug; 204(2):273-280. PubMed ID: 31967521
[TBL] [Abstract][Full Text] [Related]
28. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer.
Madalinska JB; Essink-Bot ML; de Koning HJ; Kirkels WJ; van der Maas PJ; Schröder FH
J Clin Oncol; 2001 Mar; 19(6):1619-28. PubMed ID: 11250990
[TBL] [Abstract][Full Text] [Related]
29. Long-term effects of androgen deprivation therapy in prostate cancer patients.
Basaria S; Lieb J; Tang AM; DeWeese T; Carducci M; Eisenberger M; Dobs AS
Clin Endocrinol (Oxf); 2002 Jun; 56(6):779-86. PubMed ID: 12072048
[TBL] [Abstract][Full Text] [Related]
30. Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.
Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Bill-Axelson A;
Eur Urol Oncol; 2018 Jun; 1(2):134-142. PubMed ID: 31100237
[TBL] [Abstract][Full Text] [Related]
31. Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison.
Donovan KA; Gonzalez BD; Nelson AM; Fishman MN; Zachariah B; Jacobsen PB
Psychooncology; 2018 Jan; 27(1):316-324. PubMed ID: 28557112
[TBL] [Abstract][Full Text] [Related]
32. Patients' perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey.
Lehto US; Tenhola H; Taari K; Aromaa A
Br J Cancer; 2017 Mar; 116(7):864-873. PubMed ID: 28222069
[TBL] [Abstract][Full Text] [Related]
33. Time course and predictors of symptoms after primary prostate cancer therapy.
Talcott JA; Manola J; Clark JA; Kaplan I; Beard CJ; Mitchell SP; Chen RC; O'Leary MP; Kantoff PW; D'Amico AV
J Clin Oncol; 2003 Nov; 21(21):3979-86. PubMed ID: 14581420
[TBL] [Abstract][Full Text] [Related]
34. Estimating preferences for treatments in patients with localized prostate cancer.
Ávila M; Becerra V; Guedea F; Suárez JF; Fernandez P; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Cunillera O; Pardo Y; Cots F; Ferrer M;
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):277-87. PubMed ID: 25491504
[TBL] [Abstract][Full Text] [Related]
35. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial.
Nabid A; Carrier N; Martin AG; Bahary JP; Lemaire C; Vass S; Bahoric B; Archambault R; Vincent F; Bettahar R; Duclos M; Garant MP; Souhami L
Eur Urol; 2018 Oct; 74(4):432-441. PubMed ID: 29980331
[TBL] [Abstract][Full Text] [Related]
36. Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review.
Wallis CJD; Glaser A; Hu JC; Huland H; Lawrentschuk N; Moon D; Murphy DG; Nguyen PL; Resnick MJ; Nam RK
Eur Urol; 2018 Jan; 73(1):11-20. PubMed ID: 28610779
[TBL] [Abstract][Full Text] [Related]
37. Quality of life in patients with prostate cancer.
McPherson CP; Swenson KK; Kjellberg J
Semin Oncol Nurs; 2001 May; 17(2):138-46. PubMed ID: 11383245
[TBL] [Abstract][Full Text] [Related]
38. The perspective of prostate cancer patients and patients' partners on the psychological burden of androgen deprivation and the dyadic adjustment of prostate cancer couples.
Hamilton LD; Van Dam D; Wassersug RJ
Psychooncology; 2016 Jul; 25(7):823-31. PubMed ID: 26411285
[TBL] [Abstract][Full Text] [Related]
39. [Urinary and sexual disorders following localised prostate cancer management].
Haab F; Beley S; Cornu JN; Culine S; Cussenot O; Hennequin C
Bull Cancer; 2010 Dec; 97(12):1537-49. PubMed ID: 21220229
[TBL] [Abstract][Full Text] [Related]
40. Long-term functional outcomes after treatment for localized prostate cancer.
Resnick MJ; Koyama T; Fan KH; Albertsen PC; Goodman M; Hamilton AS; Hoffman RM; Potosky AL; Stanford JL; Stroup AM; Van Horn RL; Penson DF
N Engl J Med; 2013 Jan; 368(5):436-45. PubMed ID: 23363497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
